Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scalp tools, tracking progress, targeting scalp inflammation, and avoiding certain hair treatments can improve female hair loss treatment.

Dupilumab for skin problems might reactivate hair loss in some patients.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

The Korean study found that twenty-nail dystrophy mainly affects adults, more often women, and has five distinct types with different clinical progressions.

Some improvements in the aesthetics sector have been made, but patient protection is still lacking due to no compulsory register for practitioners and non-prescription dermal fillers.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

DHCer levels in hair could be a biomarker for alopecia progression.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Scalp reduction surgery is safe and effective for certain patients with hair loss, leading to dense hair coverage and high satisfaction.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

Ebastine may help regrow hair in alopecia areata patients.

Fluconazole is the preferred treatment for deep skin infections in immunocompromised patients.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Higher p63 and CD34 levels found in specific scalp areas may affect hair loss progression.

Trichodysplasia spinulosa is a rare skin condition linked to weakened immune systems, mostly in organ transplant patients.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

The document concludes that the FOLLYSIS© system improves hair transplant processes and patient monitoring with high accuracy and less skin trauma.

La detección temprana y precisa de la pseudopelada de Brocq es crucial para detener su progresión.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.